Managing Medical Risk in Patients Seeking Psilocybin Therapy with Reid Robison, MD, MBA

Managing Medical Risk in Patients Seeking Psilocybin Therapy with Reid Robison, MD, MBA

Author: Lynn Marie Morski, MD, JD July 5, 2023 Duration: 46:09

In this episode of the Psychedelic Medicine Podcast, Dr. Reid Robison joins to discuss managing medical risk in patients seeking psilocybin therapy. Dr. Robison is a board-certified psychiatrist and Chief Clinical Officer at Numinus, overseeing the company's psychedelic and mental health services across the US and Canada. He has led over 200 clinical trials in neuropsychiatry, including the MAPS-sponsored MDMA-assisted therapy for eating disorders study, and several other psychedelic studies with psilocybin, LSD and DMT.

In this conversation, Dr. Robison begins by sharing how researchers have been determining guidelines for managing medical risks associated with psilocybin and how this guidance may shift as research continues in real-world settings at larger scales. He also discusses the intricacies of psilocybin's pharmacokinetics and how the substance interacts with common psychiatric medications such as SSRI antidepressants. In closing, Dr. Robison emphasizes the importance of keeping a close eye on potential psychological risks of psilocybin and other psychedelics, especially amid the excitement stemming from the incredible potential of these medicines.

 

In this episode:

  • The emerging medical indications for psilocybin therapy
  • How the research into psilocybin has developed in the past few years
  • The pharmacokinetics of psilocybin
  • Medication interactions with psilocybin
  • Risks of serotonin syndrome
  • Absolute vs relative contraindications
  • Psilocybin's effect on QT interval and heart valves
  • The Psychedelic Medicine Association's "Psilcobyin-Informed Clinicians" database comprised of practitioners who have completed the course

 

Quotes:

"There's a lot to learn [about the interaction of psilocybin and SSRIs] and it's a little bit unpredictable. And some people anecdotally would say that their SSRI interfered with their trip or diminished the experience and others would say it did not." [26:22]

"Psychological risks are nontrivial, including the risk of a difficult experience—something that may even need some mental health treatment afterwards, something that may be meaningful, nontrivial for the individual for a while, and can coexist with the mystical experience. And having the most meaningful experience of your life can coincide with the most difficult." [40:43]

 

Links:

Course: Managing Medical Risk in Patients Seeking Psilocybin Therapy

Dr. Robison's website

Dr. Robison on Twitter

Dr. Robison on Instagram

Numinus website

Previous episode: Psychedelics for Eating Disorders with Reid Robison

Psychedelic Medicine Association

Porangui


Exploring the frontier of mind and medicine, the Psychedelic Medicine Podcast with Dr. Lynn Marie Morski delves into the complex world of psychedelic substances and their potential to heal. Hosted by Lynn Marie Morski, a physician and attorney, this podcast navigates the intricate intersection of cutting-edge science, clinical practice, and evolving policy. Each episode brings a grounded, expert perspective to conversations about psilocybin, MDMA, ketamine, LSD, ayahuasca, ibogaine, and other compounds, moving beyond hype to examine the real-world implications of this therapeutic renaissance. Listeners will hear detailed discussions on the latest peer-reviewed research, practical insights from medical professionals integrating these approaches, and thoughtful analysis of the legal landscape shaping access. The dialogue is rooted in a commitment to safety, ethics, and evidence, offering a clear-eyed look at both the profound promise and the challenges inherent in psychedelic medicine. Whether you're a healthcare provider, a patient, a researcher, or simply intellectually curious, this podcast provides an essential, nuanced resource for understanding how these ancient and modern substances are reshaping perspectives on mental health, consciousness, and treatment. It’s a space for serious inquiry, where complex questions about healing, neuroscience, and society are met with informed, accessible conversation.
Author: Language: English Episodes: 100

Psychedelic Medicine Podcast with Dr. Lynn Marie Morski
Podcast Episodes
Microdosing Psilocybin: Truth vs Hype with Rotem Petranker, PhD [not-audio_url] [/not-audio_url]

Duration: 47:32
In this episode Rotem Petranker, PhD joins to discuss the current state of research on microdosing psilocybin. Dr. Petranker is the co-founder of the Psychedelic Studies Research Program at the University of Toronto and…
Encore Episode: Exploring Endogenous DMT with Rick Strassman, MD [not-audio_url] [/not-audio_url]

Duration: 52:41
In this episode of the Psychedelic Medicine Podcast, Rick Strassman, MD joins to discuss the topic of endogenous DMT. Dr. Strassman is adjunct associate professor of psychiatry at the University of New Mexico in Albuquer…
Psychedelics for Stroke Healing with Steven Zeiler, MD, PhD [not-audio_url] [/not-audio_url]

Duration: 32:57
In this episode Steven Zeiler, MD, PhD joins to discuss the promise of psychedelics for stroke healing. Dr. Zeiler is an associate professor and physician at Johns Hopkins School of Medicine specializing in cerebrovascul…
Long-Term Psychedelic Integration with J. Ashley T. Booth, LCSW, MS [not-audio_url] [/not-audio_url]

Duration: 34:40
In this episode J. Ashley T. Booth, LCSW, MS joins to discuss the importance of long-term psychedelic integration. Ashley is a Los Angeles-based psychedelic therapist, IFS practitioner, and author of Quieting the Storm W…
Is Psilocybin Safe for Me? with Seth Mehr, MD [not-audio_url] [/not-audio_url]

Duration: 52:41
In this episode, Seth Mehr, MD joins to share his expertise on safety planning prior to a patient undergoing psilocybin therapy. After a 20 year career as an Emergency Medicine physician, Seth founded Cascade Psychedelic…